|
HY-100320-1mg
|
MedChemexpress LLC
|
AVE5688 [CAS 613260-13-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101056-10mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101056-100mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101056-5mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101056-50mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101250-10mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101250-100mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101250-25mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101250-5mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101250-50mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101381-1mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-10mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-100mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-25mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-5mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-50mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101576-10mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101576-100mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101576-25mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101576-5mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101576-50mg
|
MedChemexpress LLC
|
RP 70676 [CAS 136609-26-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101605-1mg
|
MedChemexpress LLC
|
Prodipine hydrochloride [CAS 31314-39-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103157-10mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103157-100mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-103157-5mg
|
MedChemexpress LLC
|
PD146176 [CAS 4079-26-9]
|
|
COVID-19-immunoregulation
|
|
